Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.

The journal of allergy and clinical immunology. In practice - 1 Feb 2019

Madrigal-Burgaleta Ricardo, Bernal-Rubio Lorena, Berges-Gimeno Maria Pilar, Carpio-Escalona Laura Victoria, Gehlhaar Patricia, Alvarez-Cuesta Emilio

Abstract excerpt

BACKGROUND: Large-scale studies of drug provocation testing (DPT) or rapid drug desensitization (RDD) for hypersensitivity to antineoplastics and biologicals are scarce and limited to a few institutions. OBJECTIVE: Our aim was to review our experience with DPT and RDD in a large number of patients with a history of hypersensitivity to antineoplastics and biologicals and summarize the practical implications of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antineoplastic Agents
Share to Biological Products

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Desensitization, Immunologic

Share to Drug Hypersensitivity

Share to Hospitals

Share to Longitudinal Studies

Share to Platinum Compounds

Share to Taxoids

Source

Identifiers

PMID: 30098410
DOI: 10.1016/j.jaip.2018.07.031

Genes

DPT

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A Large Single-Hospital Experience Using Drug Provocation Testing and Rapid Drug Desensitization in Hypersensitivity to Antineoplastic and Biological Agents.PMID 30098410Read ↗

Delving into cornerstones of hypersensitivity to antineoplastic and biological agents: value of diagnostic tools prior to desensitization.Semantic proximity Read ↗

Management of Hypersensitivity in Oncology Practice: Risk Stratification, Phenotypic Markers, and Desensitization ProtocolsSemantic proximity Read ↗

From acute phase mediators to drug provocation testing: a single center experience in the allergy work-up of adverse drug reactions to chemotherapySemantic proximity Read ↗

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: phenotypes, endotypes and management with desensitization.Semantic proximity Read ↗

Differential presentation of hypersensitivity reactions to carboplatin and oxaliplatin: Phenotypes, endotypes, and management with desensitization.Semantic proximity Read ↗

The Increasing Role of the Allergist in the Management of Infusion Reactions at the Oncology Day HospitalSemantic proximity Read ↗

Drug Hypersensitivity and Desensitizations: Mechanisms and New Approaches.Semantic proximity Read ↗

Drug hypersensitivity in the fast lane: What clinicians should know about phenotypes, endotypes, and biomarkers.Semantic proximity Read ↗

Fatal infusion reaction to cetuximab: the need for predictive risk factors and safer patient selection.Semantic proximity Read ↗

Management of adverse reactions to biologic agents.Semantic proximity Read ↗

Desensitization to Pertuzumab With a Positive Skin Test Result in a Mixed-Phenotype Hypersensitivity Reaction.Semantic proximity Read ↗

Prediction of Chemical Respiratory Sensitizers Using GARD, a Novel In Vitro Assay Based on a Genomic Biomarker SignatureSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.